Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hillstream Biopharma Inc (HILS)

Hillstream Biopharma Inc (HILS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,057
  • Shares Outstanding, K 17,603
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,470 K
  • 60-Month Beta 3.08
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.26
Trade HILS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.72
  • Most Recent Earnings $-0.16 on 08/11/23
  • Latest Earnings Date 11/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +72.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1903 +21.12%
on 09/11/23
0.2950 -21.86%
on 09/11/23
-0.0083 (-3.48%)
since 08/22/23
3-Month
0.1903 +21.12%
on 09/11/23
0.4349 -47.00%
on 07/20/23
-0.1461 (-38.79%)
since 06/22/23
52-Week
0.1903 +21.12%
on 09/11/23
2.6500 -91.30%
on 02/10/23
-0.6121 (-72.64%)
since 09/22/22

Most Recent Stories

More News
Hillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset and Announces Corporate Name Change to Tharimmune, Inc.

Expects to launch and complete a Phase 1 trial in Q4 2023

HILS : 0.2305 (+2.76%)
Shares of this Biotech Surge after Announcing Exclusive Option Agreement

A New Jersey-based %Biotech company is turning heads Tuesday morning after the company announced the signing an exclusive option agreement with %DanaFarberCancerInstitute to license technology targeting...

HILS : 0.2305 (+2.76%)
Hillstream BioPharma to Attend the 12th Annual World Orphan Drug Congress USA on July 11-13

BRIDGEWATER, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company...

HILS : 0.2305 (+2.76%)
Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments

Investigating the synergy between HSB-1216, a Ferroptosis inducer, and Immune Checkpoint Inhibitors...

HILS : 0.2305 (+2.76%)
Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments

Investigating the synergy between HSB-1216, a Ferroptosis inducer, and Immune Checkpoint Inhibitors...

HILS : 0.2305 (+2.76%)
Hillstream BioPharma Provides Corporate Update

Recent milestones include FDA Orphan Drug Designations for HSB-1216 and HSB-888 World-class scientific advisory team and growing and distinguished patent...

HILS : 0.2305 (+2.76%)
Hillstream BioPharma to Present at BioNJ's 12th Annual BioPartnering Virtual Conference Held on May 9- 13, 2022

Developed in partnership with J.P. Morgan and Johnson & Johnson Innovation, the Conference will bring together more than 500 life sciences...

HILS : 0.2305 (+2.76%)
Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Action, Targeting Drug Resistant and Devastating Cancers

HSB-1216’s active moiety in clinical pilot study produced a 71% response rate in TNBC and epithelial carcinomasHSB-1216 was recently granted Orphan Drug...

HILS : 0.2305 (+2.76%)
Hillstream BioPharma Receives Orphan Drug Designation for HSB-1216 for the Treatment of Uveal Melanoma

-Uveal melanoma is an aggressive intraocular malignancy with a poor prognosis in which 50% of patients develop metastatic disease- -Evidence implicates...

HILS : 0.2305 (+2.76%)
Hillstream BioPharma Provides Business Review with Key Pipeline Updates

Continued development and validation of HSB-1216 as a leading Ferroptosis inducer to enter the clinic Successful Closing of a $15 million Initial Public Offering on January 14, 2022 R&D Day to Review Novel...

HILS : 0.2305 (+2.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hillstream BioPharma Inc. is a biotechnology company. It involved in developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers. Hillstream BioPharma Inc. is based in BRIDGEWATER,...

See More

Key Turning Points

3rd Resistance Point 0.2682
2nd Resistance Point 0.2565
1st Resistance Point 0.2435
Last Price 0.2305
1st Support Level 0.2188
2nd Support Level 0.2071
3rd Support Level 0.1941

See More

52-Week High 2.6500
Fibonacci 61.8% 1.7104
Fibonacci 50% 1.4202
Fibonacci 38.2% 1.1299
Last Price 0.2305
52-Week Low 0.1903

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar